Recent changes to the Lipitor dosage have been made to improve patient outcomes and minimize potential risks.
In 2015, the manufacturer of Lipitor, Pfizer, voluntarily agreed to pay the US government $14 million to settle allegations of off-label marketing of the medication [1]. This led to a review of the medication's safety and efficacy.
According to the FDA, patients taking high doses of Lipitor may be at increased risk for muscle damage and kidney impairment [2]. To mitigate this risk, the FDA recommends that patients be started on a lower dose of the medication and gradually increased as needed.
In addition, some patients may require a change in dosage due to interactions with other medications. For example, the use of certain antibiotics, such as erythromycin and clarithromycin, can increase the risk of muscle damage when taken with Lipitor [3].
Patients taking Lipitor should discuss any changes to their dosage with their healthcare provider.
DrugPatentWatch.com provides information on patent expiration dates for Lipitor and other medications, which may be relevant for patients and healthcare providers [4].
Sources:
[1] https://www.justice.gov/opa/pr/pfizer-agrees-pay-14-billion-settle-civil-and-criminal-charges-related-pfizer-s-promotion
[2] https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-lipitor-atorvastatin-new-labeling-muscle-and-renal-side-effects
[3] https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-safety-and-effectiveness-lower-doses-atorvastatin-when-taken-with
[4] https://www.drugpatentwatch.com/drug/atorvastatin